国外药物经济学评价应用于专利药价格谈判制度的研究

摘要

目的：研究国外药物经济学评价在专利药价格谈判制度的应用，以期为完善我国专利药价格谈判制度提供参考和借鉴。方法：从制度设计、技术要求、评价原则等方面，比较澳大利亚和英国将药物经济学评价应用于专利药价格谈判的异同，进而发现可借鉴之处。结果：两国均将药物经济学评价作为专利药准入医保目录的决策基础，并以清晰的评价流程、科学的技术指南保证评价和谈判的公平与效率。结论：建议我国加快专利药价格谈判及其配套制度建设，建立独立的第三方药物经济学评估机构，并将药物经济学评价设计延伸至早期临床试验设计阶段。%Objective:To study on application of pharmacoeconomic evaluation in the price negotiation system of patent drugs, in or-der to provide a reference for improving China′s price negotiation system of patent drugs.Methods:From system design, technical re-quirements,evaluation principles and other aspects,compare Australia′s pharmacoeconomic evaluation in the price negotiation of patent drugs with British′s to find something available for reference.Results:The 2 countries regard pharmacoeconomic evaluation as the basis for making the decision whether bring the patent drugs into catalog of National Insurance scheduleguarantee the fairness and efficiency of evaluation and negotiation by clear process and scientific technical guidance.Conclusion:We should speed up constructing price negotia-tion of patent drugs and the supporting system,establishing an independent third party evaluation organization and extend the design of the pharmacoeconomic evaluation to the early stage of design of clinical trials.